文献速递造血干细胞移植与细胞治疗

微小RNA血清谱与慢性移植物抗宿主病

MicroRNA serum profiles and chronic graft-versus-host disease.
PubMed 文献 · Blood Adv · 2022-01-01

该研究纳入79例异基因造血干细胞移植成人患者,于移植后1年采集血清进行微小RNA(miRNA)谱分析,其中50例(63%)存在慢性移植物抗宿主病(cGVHD)征象。分析发现10个miRNA在伴与不伴cGVHD患者间差异显著(P < .005;错误发现率 <0.1),并基于3个miRNA构建了诊断模型。作者结论为cGVHD患者与非cGVHD患者miRNA表达不同,但需进一步更大规模研究验证。

要点

  • 79例异基因造血干细胞移植成人患者移植后1年血清miRNA谱分析,50例(63%)有cGVHD征象。
  • 10个miRNA在伴与不伴cGVHD患者间差异显著(P < .005;错误发现率 <0.1)。
  • 基于miR-365-3p、miR-148-3p和miR-378-3p构建的miRNA特征改善了cGVHD诊断生物标志物模型。

核心结论

  • cGVHD患者与非cGVHD患者血清miRNA表达不同,但需进一步更大规模研究验证现有发现。

研究设计与样本

  • 研究纳入79例异基因造血干细胞移植成人患者,于移植后1年采集血清样本并进行miRNA谱分析。

主要发现

  • 79例患者中50例(63%)在移植后1年随访时有cGVHD征象。
  • miRNA测序分析共检测到1380个不同miRNA至少在1例患者中检出,其中233个miRNA(17%)在超过70例患者中检出。
  • 发现10个miRNA在伴与不伴cGVHD患者间差异显著(P < .005;错误发现率 <0.1),且这10个miRNA均在超过75例患者中检出。
  • miR-365-3p、miR-148-3p、miR-122-5p、miR-378-3p和miR-192-5p这5个miRNA与cGVHD尤其相关,并通过受试者工作特征分析验证。
  • 基于miR-365-3p、miR-148-3p和miR-378-3p三个miRNA构建的miRNA特征,通过生物信息学方法和线性回归模型,显著改善了cGVHD的潜在诊断生物标志物模型。

局限性

  • 作者结论指出需进一步更大规模研究验证现有发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic graft-versus-host disease (cGVHD) is the most common long-term complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). During the last decade, the interest of micro RNAs (miRNAs) in the pathophysiological process of cGVHD has increased. The objectives of this study were to investigate a wide range of serum miRNAs in allografted patients and identify associations between miRNAs and cGVHD. The study included 79 allotransplanted adults, where serum samples were obtained 1 year after the allo-HSCT, and miRNA profiling analysis in serum was performed. Fifty of the 79 patients (63%) had signs of cGVHD at the 1-year post-allo-HSCT control. miRNA sequencing analysis revealed 1380 different miRNAs detected for at least 1 patient, whereas 233 miRNAs (17%) were detected in >70 patients. We identified 10 miRNAs that differed significantly between patients with and without cGVHD (P < .005; false discovery rate <0.1), and all of these miRNAs were detected for >75 of the patients. Furthermore, 5 distinct miRNAs, miR-365-3p, miR-148-3p, miR-122-5p, miR-378-3p, and miR-192-5p, were found to be particularly associated with cGVHD in our analysis and were validated by receiver operating characteristics analysis. Based on only 3 miRNAs, miR-365-3p, miR-148-3p, and miR-378-3p, we developed a miRNA signature that, by bioinformatic approaches and linear regression model, utterly improved our potential diagnostic biomarker model for cGVHD. We conclude that miRNAs are differently expressed among patients with and without cGVHD, although further and larger studies are needed to validate our present findings.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Reikvam H, Vo AK, Johansen S, et al. MicroRNA serum profiles and chronic graft-versus-host disease. Blood Adv. 2022. PMID: 35443023. doi:10.1182/bloodadvances.2021005930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。